Wird geladen...

Ranibizumab in diabetic macular edema

By 2050 the prevalence of diabetes will more than triple globally, dramatically increasing the societal and financial burden of this disease worldwide. As a consequence of this growth, it is anticipated that there will be a concurrent rise in the numbers of patients with diabetic macular edema (DME)...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Krispel, Claudia, Rodrigues, Murilo, Xin, Xiaoban, Sodhi, Akrit
Format: Artigo
Sprache:Inglês
Veröffentlicht: Baishideng Publishing Group Co., Limited 2013
Schlagworte:
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3874491/
https://ncbi.nlm.nih.gov/pubmed/24379922
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4239/wjd.v4.i6.310
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!